DonorsChoose, Inc. – Trademark Portfolio
Entity Type: 99
DonorsChoose, Inc. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 36 (Insurance & Financial) — 3 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 4 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include DONORSCHOOSE. The owner is based in New York, NY.
42 West 24th Street
New York, NY 10010
Showing of trademarks Trademarks
Trademark Classifications
DonorsChoose, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Insurance; financial affairs; monetary affairs; real estate affairs
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does DonorsChoose, Inc. have?
DonorsChoose, Inc. has 3 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 cancelled.
What trademark classes does DonorsChoose, Inc. file in?
DonorsChoose, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 36 (Insurance & Financial), Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 41 (Education & Entertainment). Class 36 covers insurance; financial affairs; monetary affairs; real estate affairs.
What are DonorsChoose, Inc.'s most well-known trademarks?
DonorsChoose, Inc.'s registered trademark portfolio includes well-known marks such as DONORSCHOOSE. These are among 1 currently registered trademark in the portfolio.
What is DonorsChoose, Inc.'s trademark registration success rate?
DonorsChoose, Inc. has a 33% trademark registration rate, with 1 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.